Our Mission

Dan Henriques is a Chartered Professional Accountant and brings extensive experience in finance effectiveness and financial reporting to his role at EnWave.

Prior to joining EnWave, Dan Henriques was a manager in the Assurance group at PricewaterhouseCoopers LLP (“PwC”), and supported numerous mid-market companies, including companies listed on the Toronto Stock Exchange, TSX Venture Exchange and the New York Stock Exchange, with financial reporting and compliance. While at PwC, Mr. Henriques provided clients in the manufacturing and technology sectors professional services in the areas of financial audits, financial reporting and tax.

Dan Henriques earned his Bachelors of Science with an Honours Distinction and his Diploma of Accounting at the University of British Columbia.

Brent Charleton has extensive experience working in competitive team-based environments in the public, private and not-for-profit industries. He has managed the marketing, investor relations and corporate affairs mandates for EnWave Corporation since 2010.

Brent, an ex-professional athlete, is a graduate of the Marketing Management program at the British Columbia Institute of Technology and has earned a Bachelor of Arts degree in Criminology and Communications from Simon Fraser University.

Brent Charleton has completed the Canadian Securities Course and is a holder of the right to use the Chartered Financial Analyst^® designation.

Dr. Richard Mitchell is a seasoned pharmaceutical industry professional with over three decades of experience in various management and business development roles.

He was formerly the Director of Business Development at Fred Hutchinson Cancer Research Center after holding strategic positions in many well-known pharmaceutical and technology companies, including Nastech Pharmaceutical, Adnavance Technologies and Shoreline Community College, MDS Pharma Services, among others.

Dr. Mitchell brings a scientific background paired with a strong business acumen to forge successful relationships within the biotech arena. Dr. Mitchell holds a BA in Biology, a Ph.D. in Microbiology and a Post-Doctoral in Molecular Oncology.

Leon Fu has worked with EnWave since 2000 and has been the driving force behind a number of significant design innovations on every one of the REV™ platforms.

Leon Fu is a co-author of several patents held jointly with EnWave’s founder, Dr. Tim Durance.

Leon Fu holds a B.Eng. Electronics from Petroleum University in Dong Ying, China. He has led EnWave’s engineering group along with Dr. Durance, since joining the Company.

Dr. Zhang is a seasoned R&D professional and well respected academic. His educational qualifications include a Bachelor of Engineering Degree in Seafood Processing from Ocean University of China, a Master’s Degree in Food Microbiology from the University of Manitoba and a PhD in Food Nutrition and Health (FNH) from the University of British Columbia.

An accomplished academic, he has co-authored more than 10 research papers and 2 patents.

Prior to joining EnWave, Dr.Zhang worked in R&D and technical sales roles in the natural anti-microbial enzyme applications sector for more than 10 years. His expertise includes microbiology testing methods, shelf life/challenge studies, anti-microbial efficacy and interaction evaluation.

Dr. Zhang co-developed the microencapsulation method for enzymes using the REV™ technology with Dr. Durance during his PhD study.

Dr. Sandberg is a former long-time employee of Lipton, a division of Unilever Canada Inc. and holds a Ph.D. in Food Science from the University of British Columbia.

He was the Program Head of Food Technology, School of Health Sciences, at the British Columbia Institute of Technology and an active contributor to many of EnWave’s product development projects for potential commercial licensees.

Dr. Noorbakhsh’s professional experience includes microbiology and analytical testing methods, molecular and cell biology techniques, standardization, and different management systems based on ISO standards.

She is the author of 20 scientific publications, two book chapters and 18 scientific presentations.

For more than thirteen years, Reihaneh served the Iranian Institute of Standard and Industrial Research (ISIRI) as the Director of Research and Training Department, Manager of Reference Laboratories for Food Additives and Adulteration, Director of Certification System for National Laboratory Accreditation based on ISO/IEC 17025, and as a food industry inspector.

Mr. Budreski joins EnWave with over 30 years of extensive capital markets and executive management experience. John P. A. Budreski has a professional history of advancing and accelerating businesses, as well as tangible engineering experience.

He was formerly a Vice Chairman of Cormark Securities Inc. from 2009 to 2012 and President and CEO of Orion Securities Inc. from 2005 to 2007, prior to its successful sale to Macquarie Bank. He has filled the roles of a Managing Director of Equity Capital Markets and Head of Investment Banking for Scotia Capital Inc. from March 1998 to February 2005 after starting out as a Managing Director of US Institutional Equity Group for Scotia Capital. He also held senior roles in investment banking and equity sales and trading for RBC Dominion Securities.

Mr. Budreski is currently a Director of Sandstorm Gold Ltd., Alaris Royalty Corporation and Input Capital. He is also the Chief Executive Officer and a Director of Morien Resources Corporation.